EdwardTaFryMD

PubMed

• Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and th...
  Louise Bowman, Franz Weidinger, Michelle A Albert, Edward T A Fry, Fausto J Pinto> ;Circulation. 2023 Mar 21
• Randomized trials fit for the 21st century. A joint opinion from the European Society of Cardiology, American Heart Association, American College of Cardiology, and th...
  Louise Bowman, Franz Weidinger, Michelle A Albert, Edward T A Fry, Fausto J Pinto> ;European Heart Journal. 2023 Mar 14
• Randomized Trials Fit for the 21st Century: A Joint Opinion From the European Society of Cardiology, American Heart Association, American College of Cardiology, and th...
  Louise Bowman, Franz Weidinger, Michelle A Albert, Edward T A Fry, Fausto J Pinto> ;Journal of the American College of Cardiology. 2023 Mar 28
• 8 citations
  The Market Reacts Quickly: Changes in Paclitaxel Vascular Device Purchasing Within the Ascension Healthcare System.
  Peter Monteleone, Subhash Banerjee, Priya Kothapalli, Ariel Dora Stern, Daniel C. Fehder, Ron Ginor, Dominic Vollmar, Edward T. A. Fry, Mark J. Pirwitz> ;The Journal of Invasive Cardiology. 2020 Jan 1
• 3 citations
  President's page: CV workforce projections are not what they seem.
  Patrick T. O'Gara, Christopher J. Cooper, Edward T.A. Fry> ;Journal of the American College of Cardiology. 2014 May 13
• 57 citations
  Presentation and therapy of spontaneous coronary artery dissection and comparisons of postpartum versus nonpostpartum cases.
  Hiroki Ito, Lee Taylor, Martha Bowman, Edward T.A. Fry, James B. Hermiller, James Van Tassel> ;American Journal of Cardiology. 2011 Jun 1
• 65 citations
  First Clinical Application of an Actively Reversible Direct Factor IXa Inhibitor as an Anticoagulation Strategy in Patients Undergoing Percutaneous Coronary Intervention
  Mauricio G. Cohen, Drew A. Purdy, Joseph S. Rossi, Liliana Grinfeld, Shelley K. Myles, Laura H. Aberle, Adam Greenbaum, Edward T.A. Fry, Mark Y. Chan, Ross M. Tonkens,...> ;Circulation. 2010 Aug 10
• 1 citations
  The pharmacodynamics of enoxaparin in percutaneous coronary intervention with precise rapid enoxaparin loading (PEPCI-PRE study).
  Jack L. Martin, Edward T.A. Fry, Todd Martin, Trevor Atherley, Seth S. Martin, Marvin J. Slepian> ;Journal of Thrombosis and Thrombolysis. 2009 Mar 17
• 4 citations
  Strategies for optimizing outcomes in the NSTE-ACS patient The CATH (cardiac catheterization and antithrombotic therapy in the hospital) Clinical Consensus Panel Report.
  Mauricio G. Cohen, Jose G Diez, Edward T.A. Fry, Sunil V. Rao, Ferguson Jj rd, James P. Zidar, Glenn N. Levine, Shani J> ;Journal of Invasive Cardiology. 2006 Dec 1
• 60 citations
  Treatment of Left Anterior Descending Coronary Artery Disease With Sirolimus-Eluting Stents
  Neil Sawhney, Jeffrey W. Moses, Martin B. Leon, Richard E. Kuntz, Jeffrey J. Popma, William Bachinsky, Theodore A. Bass, Samuel DeMaio, Edward T. A. Fry, David R. Holm...> ;Circulation. 2004 Jul 27
• 51 citations
  Reliable anticoagulation with enoxaparin in patients undergoing percutaneous coronary intervention: The pharmacokinetics of enoxaparin in PCI (PEPCI) study
  Jack L. Martin, Edward T.A. Fry, Ger-Jan Sanderink, Trevor Atherley, Colette M Guimart, Paul Chevalier, Marie-Laure Ozoux, Catherine Pensyl, Frederique Bigonzi> ;Catheterization and Cardiovascular Interventions. 2004 Feb 1
• 6 citations
  Pharmacoinvasive management of acute coronary syndrome in the setting of percutaneous coronary intervention: evidence-based, site- and spectrum-of-care strategies for ...
  Dean J. Kereiakes, James E. Tcheng, Edward T.A. Fry, Deepak L. Bhatt, Bosker G, Jose G Diez, Ferguson Jj rd, Glenn N. Levine, Gary L. Schaer, James P. Zidar, Cath Clin...> ;Journal of Invasive Cardiology. 2003 Sep 1
• 2227 citations
  Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial.
  Steven R. Steinhubl, Peter B. Berger, J. Tift Mann, Edward T.A. Fry, Augustin DeLago, Charles Wilmer, Eric J. Topol> ;JAMA. 2002 Nov 20
• 24 citations
  Safety and efficacy of only 2 weeks of ticlopidine therapy in patients at increased risk of coronary stent thrombosis: Results from the Antiplatelet Therapy alone vers...
  Peter B. Berger, Kenneth W. Mahaffey, Susan J. Meier, Christopher E. Buller, Wayne Batchelor, Edward T.A. Fry, James P. Zidar> ;American Heart Journal. 2002 May 1
• 34 citations
  A randomized, placebo-controlled trial of enoxaparin after high-risk coronary stenting: the ATLAST trial.
  Wayne Batchelor, Kenneth W. Mahaffey, Peter B. Berger, Ezra Deutsch, Susan Meier, Vic Hasselblad, Edward T.A. Fry, Paul S. Teirstein, Allan M. Ross, Cynthia Binanay, J...> ;Journal of the American College of Cardiology. 2001 Nov 15
• 108 citations
  Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention.
  Dean J. Kereiakes, Cindy L. Grines, Edward T.A. Fry, Paolo Esente, D. A. Hoppensteadt, Mark Midei, L Barr, William H. Matthai, M Todd, Thomas M. Broderick, R Rubinstei...> ;Journal of Invasive Cardiology. 2001 Apr 1
• 62 citations
  Dalteparin in combination with abciximab during percutaneous coronary intervention
  Dean J. Kereiakes, Neal S. Kleiman, Edward T.A. Fry, Grace Mwawasi, Rose Lengerich, Kelly Maresh, Mary Lynn Burkert, Joseph W. Aquilina, Michael DeLoof, Thomas M. Brod...> ;American Heart Journal. 2001 Mar 1
• 34 citations
  Combination enoxaparin and abciximab therapy during percutaneous coronary intervention: "NICE guys finish first".
  Dean J. Kereiakes, Edward T.A. Fry, William H. Matthai, Niederman A, L Barr, Bruce R. Brodie, James P. Zidar, Paul N. Casale, Christy G, David J. Moliterno, Lengerich ...> ;Journal of Invasive Cardiology. 2000 Feb 1
• 29 citations
  Comparison of six-month outcome of coronary artery stenting in patients 75 years of age
  Tony K. Nasser, Edward T.A. Fry, Kingsley Annan, Yazan Khatib, Thomas F. Peters, James W. Vantassel, Charles M. Orr, Bruce F. Waller, Rodger P. Pinto, Cass A. Pinkerto...> ;American Journal of Cardiology. 1997 Oct 15
• Coronary artery and saphenous vein graft remodeling: a review of histologic findings after various interventional procedures--Part VI.
  Waller BF, Orr CM, VanTassel J, Peters T, Fry E, Hermiller J, Grider LD> ;Clin Cardiol. 1997-02-01
• Coronary artery and saphenous vein graft remodeling: a review of histologic findings after various interventional procedures--Part V.
  Waller BF, Orr CM, Van Tassel J, Peters T, Fry E, Hermiller J, Grider LD> ;Clin Cardiol. 1997-01-01
• Coronary artery and saphenous vein graft remodeling: a review of histologic findings after various interventional procedures--Part IV.
  Waller BF, Orr CM, VanTassel J, Peters T, Fry E, Hermiller J, Grider LD> ;Clin Cardiol. 1996-12-01
• Coronary artery and saphenous vein graft remodeling: A review of histologic findings after various interventional procedures--Part III.
  Waller BF, Orr CM, VanTassel J, Peters T, Fry E, Hermiller J, Grider LD> ;Clin Cardiol. 1996-11-01
• 9 citations
  Abrupt (<1 day), acute (<1 week), and early (<1 month) vessel closure at the angioplasty site. Morphologic observations and causes of closure in 130 necropsy patients ...
  Bruce F. Waller, Edward T.A. Fry, Thomas F. Peters, James B. Hermiller, Charles M. Orr, James Vantassel, Cass A. Pinkerton> ;Clinical Cardiology. 1996 Nov 1
• Coronary artery and saphenous vein graft remodeling: a review of histologic findings after various interventional procedures--Part II.
  Waller BF, Orr CM, VanTassel J, Peters T, Fry E, Hermiller J, Grider LD> ;Clin Cardiol. 1996-10-01
• Join now to see all